Effects of salicylic acid derivatives on red blood cell membranes.
Salicylamide, sodium salicylate and acetylsalicylic acid are salicylic acid derivates. They differ in their substitution on the benzene ring and may have different effects on membranes. Red blood cells were used as a prototypical cellular system regarding drug mediated plasma bilayer effects. Established photometric methods sensing tiny changes of red blood cell morphology at rest (red blood cell shape) and at very low shear forces (red blood cell stiffness, red blood cell relaxation time) were applied. The derivative induced effects were detected in a time- and dose-dependent manner. Salicylamide induced a most pronounced echinocytic shape at 5 mM. The shape effect was smaller above as well as below 5 mM. Sodium salicylate induced echinocytes with increasing concentrations showing a saturation above 10 mM. In contrast, the shape was not affected by acetylsalicylic acid. All shape changes occurred within 2 min, and were reversible. The above tendencies were in parallel to a slight red blood cell stiffening. The relaxation time continuously increased with increasing concentrations in both salicylamide and sodium salicylate, with salicylamide always acting stronger. Acetylsalicylic acid again showed no effect. We hypothesize that the observed effects of sodium salicylate and salicylamide are due to their phenolic character mediating a molecular hydrophobicity. According to the bilayer couple hypothesis this would lead to an insertion into the red blood cells outer plasma bilayer leaflet. The extension induced here would cause a positive membrane bending leading to echinocytic shapes and the observed loss of red blood cell fluidity. In contrast, the hydrophilic aspirin would penetrate and thus not affect the red blood cell plasma membrane.
Li
A
A
Department of Cell Biophysics, University of Applied Sciences Aachen, Germany.
Seipelt
H
H
Müller
C
C
Shi
Y
Y
Artmann
M
M
D001241:Aspirin / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects*; D048429:Cell Size / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004910:Erythrocyte Membrane / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D010783:Photometry; D012457:Salicylamides / Q000494:pharmacology*; D012459:Salicylates / Q000494:pharmacology; D012980:Sodium Salicylate / Q000494:pharmacology*; D013997:Time Factors
D012457:Salicylamides; D012459:Salicylates; C031060:salicylamide; D001241:Aspirin; D012980:Sodium Salicylate